Molina Healthcare Stock (-26%): Profit Warning on Soaring Costs

Molina Healthcare (MOH), a managed care company, experienced a dramatic -26% drop on February 6, 2026. The plunge was triggered by a severe cut in its 2026 profit guidance, which cited escalating medical costs and challenges with a key Medicaid contract. The aggressive selling pressure reflects a significant reset of expectations. But is this a one-time event or a sign of deeper structural issues?

The fundamental picture for Molina has soured considerably, with the market reacting to a significant earnings downgrade and strategic shifts.

• Molina slashed its 2026 adjusted EPS guidance to at least $5.00, far below the consensus of nearly $13.00.
• The company reported a surprise Q4 2025 adjusted loss of $2.75 per share, drastically missing estimates.
• Management blamed soaring medical costs, issues with a new Medicaid contract, and underperformance in its Medicare Advantage Part D product, which it plans to exit in 2027.

Trade Mechanics & Money Flow

Trade Mechanics: What Happened?

The stock’s sharp decline was accompanied by a massive surge in volume, indicating institutional capitulation.

• MOH closed at approximately $131.65, hitting a new 52-week low of $125.00 during the session.
• The previous day’s close was $176.84.
• Trading volume surged to 10.34M shares, a significant increase from its average volume of 1.64M, confirming the aggressive selling pressure.

How Is The Money Flowing?

The move was clearly driven by institutional selling in response to the shocking guidance cut, with retail likely following the downward momentum.

• The pre-market collapse of over 30% suggests that the news prompted an immediate and widespread institutional reassessment.
• Well-known investor Michael Burry, however, expressed a contrarian bullish view on the stock’s plunge.
• The stock breaking its 52-week low of $133.40 signaled a capitulation event, likely triggering stop-loss orders and further retail selling.

Understanding trade mechanics, money flow, and price behavior can give you and edge. See more.

What Next?

FADE. While the sell-off was severe, the drastic cut to 2026 guidance points to significant operational and profitability challenges that are unlikely to be resolved quickly. The ‘trough year’ narrative from management may not be enough to attract buyers until there is clear evidence of stabilizing medical cost trends and successful execution of their strategic shift away from certain Medicare products. Watch the $115.00 level, which is a prior 52-week low mentioned in some reports. A break below this level would indicate further downside as it would signal a failure to find support even after a catastrophic news event.

That’s it for now, but so much more goes into evaluating a stock from long-term investment perspective. We make it easy with our Investment Highlights

Not comfortable with MOH stock? Consider PORTFOLIOS instead.

A Multi Asset Portfolio Gives You Safer Smarter Growth

Stocks soar and sink but bonds commodities and other assets balance the ride. A multi asset portfolio keeps returns steadier and reduces single market risk.

The asset allocation framework of Trefis’ Boston-based, wealth management partner yielded positive returns during the 2008-09 period when the S&P lost more than 40%. Our partner’ strategy now includes Trefis High Quality Portfolio, which has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices